PepFinder
GLP-1 receptor agonistGLP-1 Agonists

Albiglutide (Tanzeum)

A once-weekly GLP-1 receptor agonist created by fusing two GLP-1 molecules to albumin. Was FDA-approved for type 2 diabetes but voluntarily withdrawn from market in 2018 due to commercial reasons, not safety.

blood-sugar-controlweight-losslong-actingwithdrawn
3D Structure
3D Structure
72970 Da
Molecular Weight72,970 Da
FormulaC148H223N39O46
PubChem CID122173812
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity16432059247528913307m/z3284.6
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

A once-weekly GLP-1 receptor agonist created by fusing two GLP-1 molecules to albumin. Was FDA-approved for type 2 diabetes but voluntarily withdrawn from market in 2018 due to commercial reasons, not…